The aim of the paper was to describe a new formula (Antilip®) consisting of very low dosages of polyglucosamine, phytosterols and Monascus purpureus. It was given to subjects affected by high cholesterol levels.

Antilip®: treatment of subjects with high total cholesterol tolerability and efficacy in a short-term registry study / M.R. Cesarone, A. Ledda, G. Belcaro, A. Ricci, S. Stuard, L. Pellegrini, E. Ippolito, U. Cornelli. - In: PANMINERVA MEDICA. - ISSN 0031-0808. - 52:2 Suppl 1(2010 Jun), pp. 15-19.

Antilip®: treatment of subjects with high total cholesterol tolerability and efficacy in a short-term registry study

E. Ippolito
Penultimo
;
2010

Abstract

The aim of the paper was to describe a new formula (Antilip®) consisting of very low dosages of polyglucosamine, phytosterols and Monascus purpureus. It was given to subjects affected by high cholesterol levels.
Plant Extracts; Humans; Aged; Phytosterols; Cholesterol; Exercise; Registries; Adult; Treatment Outcome; Monascus; Acetylglucosamine; Middle Aged; Diet; Hypercholesterolemia; Female; Male
Settore MED/22 - Chirurgia Vascolare
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/210136
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact